Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-site, Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Dronabinol for the Treatment of Agitation in Outpatient With Dementia

NCT05612711 is registered in ClinicalTrials.gov with Ralph H. Johnson VA Medical Center as lead sponsor.

NCT NCT05612711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05612711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-site, Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Dronabinol for the Treatment of Agitation in Outpatient With Dementia
Lead sponsor
Ralph H. Johnson VA Medical Center
Phase
Phase 2
Overall status
Withdrawn
Start date
November 30, 2023
Completion date
November 30, 2026
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

agitation,psychomotor, behavioral symptoms, dementia moderate, dementia severe